Share on StockTwits
 

MannKind Corp. (NASDAQ:MNKD) is scheduled to post its quarterly earnings results on Tuesday, February 18th. Parties interested in registering for the company’s conference call can do so using this link.

Shares of MannKind Corp. (NASDAQ:MNKD) opened at 5.58 on Monday. MannKind Corp. has a one year low of $2.46 and a one year high of $8.70. The stock has a 50-day moving average of $5.57 and a 200-day moving average of $5.6. The company’s market cap is $1.680 billion. MannKind Corp. also was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 57,387,598 shares, a growth of 11.5% from the January 15th total of 51,450,894 shares. Currently, 30.2% of the shares of the company are short sold. Based on an average daily volume of 6,549,011 shares, the days-to-cover ratio is presently 8.8 days.

MNKD has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of MannKind Corp. in a research note on Monday, December 30th. They now have a $5.50 price target on the stock. Analysts at Piper Jaffray initiated coverage on shares of MannKind Corp. in a research note on Tuesday, November 26th. They set a “neutral” rating and a $5.00 price target on the stock. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $6.38.

MannKind Corporation (NASDAQ:MNKD) is a development-stage biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.